Genomics

The Mount Sinai PsychAD Study (MSSMPsychAD)

The Mount Sinai PsychAD Study provides population-scale single-nucleus RNA sequencing data from the dorsolateral prefrontal cortex of 1,494 postmortem brain donors. The study encompasses more than 6.3 million nuclei from individuals with neurodegenerative diseases, serious mental illnesses, and neurotypical controls. Represented conditions include Alzheimer's disease, Parkinson's disease, schizophrenia, bipolar disorder, diffuse Lewy body dementia, vascular dementia, and additional neurological and psychiatric disorders. The study also includes genotype, clinical, neuropathological, and neuropsychiatric symptom data where available.

Listed for discovery. Access is provided by the original publisher under its terms.

Data coverage

The Mount Sinai PsychAD Study provides population-scale single-nucleus RNA sequencing data from the dorsolateral prefrontal cortex of 1,494 postmortem brain donors. The study encompasses more than 6.3 million nuclei from individuals with neurodegenerative diseases, serious mental illnesses, and neurotypical controls. Represented conditions include Alzheimer's disease, Parkinson's disease, schizophrenia, bipolar disorder, diffuse Lewy body dementia, vascular dementia, and additional neurological and psychiatric disorders. The study also includes genotype, clinical, neuropathological, and neuropsychiatric symptom data where available.

Access & permitted use

Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.

https://adknowledgeportal.synapse.org/Explore/Studies/DetailsPage/StudyDetails?Study=syn52160016Acknowledgement

Need help sourcing data?

Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.

Request sourcing help

Related data sources